Wave Life Sciences Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Wave Life Sciences Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- Singapore
- Ticker symbol
- WVE
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001631574
Board of directors
-
Adrian Rawcliffe · DirectorSince 2023
-
Aik Na Tan · DirectorSince 2023
-
Christian O. Henry · DirectorSince 2023
-
Gregory L. Verdine · DirectorSince 2023
-
Heidi L. Wagner · DirectorSince 2023
-
Ken Takanashi · DirectorSince 2023
-
Mark Corrigan · DirectorSince 2023
-
Paul Bolno · Director · President and CEOSince 2023
- Since 2023
- Since 2023
Chief executives
Paul Bolno
· President and CEO
Dates unknown
Board connections
4 of this board's directors also sit on 26 other boards.
- via Peter Kolchinsky and Rajeev M. Shah
- via Peter Kolchinsky and Rajeev M. Shah
- via Peter Kolchinsky and Rajeev M. Shah
- via Peter Kolchinsky and Rajeev M. Shah
- via Peter Kolchinsky and Rajeev M. Shah
- via Peter Kolchinsky and Rajeev M. Shah
- via Peter Kolchinsky and Rajeev M. Shah
- via Peter Kolchinsky and Rajeev M. Shah
- via Peter Kolchinsky and Rajeev M. Shah
- via Peter Kolchinsky and Rajeev M. Shah
- via Peter Kolchinsky and Rajeev M. Shah
- via Peter Kolchinsky and Rajeev M. Shah
- via Peter Kolchinsky and Rajeev M. Shah
- via Peter Kolchinsky and Rajeev M. Shah
- via Peter Kolchinsky and Rajeev M. Shah
- via Peter Kolchinsky and Rajeev M. Shah
- via Peter Kolchinsky and Rajeev M. Shah
- via Peter Kolchinsky and Rajeev M. Shah
- via Peter Kolchinsky and Rajeev M. Shah
- via Peter Kolchinsky and Rajeev M. Shah
- via Peter Kolchinsky and Rajeev M. Shah
- via Peter Kolchinsky and Rajeev M. Shah
- via Peter Kolchinsky and Rajeev M. Shah
- via Peter Kolchinsky and Rajeev M. Shah
- via Christian O. Henry
- via Paul Bolno
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $82,561,068
- 6 purchases by 2 insiders
- Sold, last 12 months
- $16,182,860
- 47 sales by 11 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 12, 2026 | Adrian Rawcliffe Director | Open-market sale | −12,700 | $5.29 | $67,183 |
| Aug 11, 2026 | Ken Takanashi Director | Open-market sale | −3,864 | $6.01 | $23,223 |
| Aug 11, 2026 | Aik Na Tan Director | Open-market sale | −432 | $6.01 | $2,596 |
| Aug 11, 2026 | Heidi L. Wagner Director | Option exercise | +7,000 | $5.97 | $41,790 |
| Aug 11, 2026 | Heidi L. Wagner Director | Open-market sale | −7,000 | $6.01 | $42,070 |
| Mar 30, 2026 | RA CAPITAL MANAGEMENT, L.P. Director, 10% owner | Open-market purchase | +971,091 | $6.50 | $6,312,092 |
| Mar 27, 2026 | RA CAPITAL MANAGEMENT, L.P. Director, 10% owner | Open-market purchase | +2,495,623 | $6.43 | $16,046,856 |
| Mar 26, 2026 | RA CAPITAL MANAGEMENT, L.P. Director, 10% owner | Open-market purchase | +4,954,558 | $6.06 | $30,024,621 |
| Mar 26, 2026 | RA CAPITAL MANAGEMENT, L.P. Director, 10% owner | Open-market purchase | +351,224 | $6.38 | $2,240,809 |
| Mar 23, 2026 | Ken Takanashi Director | Derivative conversion | +3,901,348 | — | — |
| Feb 26, 2026 | Francis Chris Officer (See Remarks) | Option exercise | +17,900 | $3.87 | $69,273 |
| Feb 26, 2026 | Francis Chris Officer (See Remarks) | Open-market sale | −17,900 | $15.09 | $270,111 |
| Feb 26, 2026 | Francis Chris Officer (See Remarks) | Option exercise | +15,294 | $4.75 | $72,647 |
| Feb 26, 2026 | Francis Chris Officer (See Remarks) | Open-market sale | −15,294 | $15.00 | $229,410 |
| Feb 9, 2026 | Moran Kyle Officer (Chief Financial Officer) | Open-market sale | −3,588 | $13.45 | $48,259 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.